The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Open accessAbstract
Rationale: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Objectives: We sought to identify donor, recipient, and perioperative risk factors for PGD. Methods: We performed a 10-center prospective cohort study enrolled between March 2002 and December 2010 (the Lung Transplant Outcomes Group). The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD at 48 or 72 hours post-transplant. The association of potential risk factors with PGD was analyzed using multivariable conditional logistic regression. Measurements and Main Results: A total of 1,255 patients from 10 centers were enrolled; 211 subjects (16.8%) developed grade 3 PGD. In multivariable models, independent risk factors for PGD were any history of donor smoking (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2–2.6; P = 0.002); FiO2 during allograft reperfusion (OR, 1.1 per 10% increase in FiO2; 95% CI, 1.0–1.2; P = 0.01); single lung transplant (OR, 2; 95% CI, 1.2–3.3; P = 0.008); use of cardiopulmonary bypass (OR, 3.4; 95% CI, 2.2–5.3; P < 0.001); overweight (OR, 1.8; 95% CI, 1.2–2.7; P = 0.01) and obese (OR, 2.3; 95% CI, 1.3–3.9; P = 0.004) recipient body mass index; preoperative sarcoidosis (OR, 2.5; 95% CI, 1.1–5.6; P = 0.03) or pulmonary arterial hypertension (OR, 3.5; 95% CI, 1.6–7.7; P = 0.002); and mean pulmonary artery pressure (OR, 1.3 per 10 mm Hg increase; 95% CI, 1.1–1.5; P < 0.001). PGD was significantly associated with 90-day (relative risk, 4.8; absolute risk increase, 18%; P < 0.001) and 1-year (relative risk, 3; absolute risk increase, 23%; P < 0.001) mortality. Conclusions: We identified grade 3 PGD risk factors, several of which are potentially modifiable and should be prioritized for future research aimed at preventative strategies. Clinical trial registered with www.clinicaltrials.gov (NCT00552357).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We know from prior work that recipient characteristics including primary PH or pulmonary fibrosis and increasing mPAP are risk factors for PGD.29–31”
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Christie, J. D., Carby, M., Bag, R., Corris, P., Hertz, M., & Weill, D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.11.049 · Cited by 762 · cited 1×
“In 2005, the International Society for Heart and Lung Transplantation (ISHLT) standardized the PGDdefinition to facilitate research on risk factors associated with the development of this syndrome (7).”
BackgroundSelf-citationChristie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.004 · Cited by 630 · cited 2×
“Additionally, the most recent ISHLT report includes 2004–2010 as a single era when presenting survival analyses (34).”
BackgroundSelf-citationTransfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
Gajic, O., Rana, R., Winters, J. L., Yilmaz, M., Mendez, J. L., Rickman, O. B., O'Byrne, M. M., Evenson, L. K., Malinchoc, M., DeGoey, S. R., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-271oc · Cited by 430 · cited 1×
“Nonetheless, because blood product transfusion in-and-of-itself is associated with ALI in at-risk groups this finding may warrant further research into mechanisms of increased grade 3 PGD risk (31).”
Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome
Daud, S. A., Yusen, R. D., Meyers, B. F., Chakinala, M. M., Walter, M. J., Aloush, A. A., Patterson, G. A., Trulock, E. P., & Hachem, R. R. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1079oc · Cited by 420 · cited 5×
“Pulmonary arterial hypertension 12 (6) 28 (3)”
BackgroundMethodInfluentialPutensen, C., Theuerkauf, N., Zinserling, J., Wrigge, H., & Pelosi, P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00011 · Cited by 372
The Effect of Primary Graft Dysfunction on Survival after Lung Transplantation
Christie, J. D., Kotloff, R. M., Ahya, V. N., Tino, G., Pochettino, A., Gaughan, C., DeMissie, E., & Kimmel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1243oc · Cited by 351 · cited 1×
“The incidence of PGD is 10–30% and is the major cause of mortality within the first post-transplant year (1, 2).”
BackgroundSelf-citationEISNER, M. D., THOMPSON, T., HUDSON, L. D., LUCE, J. M., HAYDEN, D., SCHOENFELD, D., MATTHAY, M. A., & the Acute Respiratory Distress Syndrome Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2011093 · Cited by 290
Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Christie, J. D., Kotloff, R. M., Pochettino, A., Arcasoy, S. M., Rosengard, B. R., Landis, J. R., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.124.4.1232 · Cited by 275 · cited 1×
“None of the previously identified donor variables, including sex, race, age, or mode of death were significantly associated with grade 3 PGD (14, 18, 20).”
BackgroundSelf-citationPrimary Graft Dysfunction and Long-term Pulmonary Function After Lung Transplantation
Whitson, B. A., Prekker, M. E., Herrington, C. S., Whelan, T. P. M., Radosevich, D. M., Hertz, M. I., & Dahlberg, P. S. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.018 · Cited by 265 · cited 1×
“PGD leads to increased duration of mechanical ventilation and intensive care unit length of stay, poor functional outcomes, and increased risk of bronchiolitis obliterans syndrome (3, 4).”
Background
Cited by
Snell, G. I., Yusen, R. D., Weill, D., Strueber, M., Garrity, E., Reed, A., Pelaez, A., Whelan, T. P., Perch, M., Bag, R., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.021 · Cited by 703
“In a more recent large prospective multicenter study, Diamond et al 11 found increased 30-day, 90-day, and 1-year mortality with PGD 3 at T48 to T72, with attributable mortality risks ranging from 18% to 22%.”
InfluentialSelf-citationPathogenesis of Acute Respiratory Distress Syndrome
Huppert, L., Matthay, M., & Ware, L. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1683996 · Cited by 459
Self-citationHuman distal airways contain a multipotent secretory cell that can regenerate alveoli
Basil, M. C., Cardenas-Diaz, F. L., Kathiriya, J. J., Morley, M. P., Carl, J., Brumwell, A. N., Katzen, J., Slovik, K. J., Babu, A., Zhou, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04552-0 · Cited by 322
Self-citationSayah, D. M., Mallavia, B., Liu, F., Ortiz-Muñoz, G., Caudrillier, A., DerHovanessian, A., Ross, D. J., Lynch III, J. P., Saggar, R., Ardehali, A., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1086oc · Cited by 249
“The second cohort consisted of subjects enrolled in the Lung Transplant Outcomes Group prospective cohort study (31).”
BackgroundSelf-citationMachuca, T. N., Collaud, S., Mercier, O., Cheung, M., Cunningham, V., Kim, S. J., Azad, S., Singer, L., Yasufuku, K., de Perrot, M., et al. (2015) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.11.039 · Cited by 248
Hoetzenecker, K., Schwarz, S., Muckenhuber, M., Benazzo, A., Frommlet, F., Schweiger, T., Bata, O., Jaksch, P., Ahmadi, N., Muraközy, G., et al. (2018) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.10.144 · Cited by 242
“org/article/S0022-5223(17)32773-3/fulltext.”
Warnecke, G., Van Raemdonck, D., Smith, M. A., Massard, G., Kukreja, J., Rea, F., Loor, G., De Robertis, F., Nagendran, J., Dhital, K. K., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30136-x · Cited by 222
Ius, F., Kuehn, C., Tudorache, I., Sommer, W., Avsar, M., Boethig, D., Fuehner, T., Gottlieb, J., Hoeper, M., Haverich, A., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.07.095 · Cited by 222
Warnecke, G., Moradiellos, J., Tudorache, I., Kühn, C., Avsar, M., Wiegmann, B., Sommer, W., Ius, F., Kunze, C., Gottlieb, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61344-0 · Cited by 211
Diamond, J. M., Arcasoy, S., Kennedy, C. C., Eberlein, M., Singer, J. P., Patterson, G. M., Edelman, J. D., Dhillon, G., Pena, T., Kawut, S. M., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.020 · Cited by 185
“factors by an unadjusted meta-analysis, however, a large multicenter cohort study did not confirm these findings with multivariable adjustment (8, 16).”
BackgroundMethodSelf-citationBermudez, C. A., Shiose, A., Esper, S. A., Shigemura, N., D’Cunha, J., Bhama, J. K., Richards, T. J., Arlia, P., Crespo, M. M., & Pilewski, J. M. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.06.072 · Cited by 183
Self-citationBiscotti, M., Yang, J., Sonett, J., & Bacchetta, M. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.07.061 · Cited by 180
Self-citationTudorache, I., Sommer, W., Kühn, C., Wiesner, O., Hadem, J., Fühner, T., Ius, F., Avsar, M., Schwerk, N., Böthig, D., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000348 · Cited by 173
“Primary graft dysfunction (PGD) is frequently cited as causing early morbidity andmortality in PAH patients.(10,11) Some have speculated that PGD in PAH patients might be attributed to endothelial injury from shear-stress forces applied by a well-trained right ventricle (RV) resulting in subsequent pulmonary edema.”
BackgroundLoor, G., Warnecke, G., Villavicencio, M. A., Smith, M. A., Kukreja, J., Ardehali, A., Hartwig, M., Daneshmand, M. A., Hertz, M. I., Huddleston, S., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30200-0 · Cited by 164
Liu, Y., Liu, Y., Su, L., & Jiang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092773 · Cited by 180
“45 yr) or younger (,21 yr) donor age, and closed head injury as a cause of death [9,10,18,19,20].”
BackgroundMethodResultInfluentialCorris, P. A., Ryan, V. A., Small, T., Lordan, J., Fisher, A. J., Meachery, G., Johnson, G., & Ward, C. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-205998 · Cited by 164
Hoetzenecker, K., Benazzo, A., Stork, T., Sinn, K., Schwarz, S., Schweiger, T., Klepetko, W., Kifjak, D., Baron, D. M., Hager, H., et al. (2020) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.10.155 · Cited by 157
Panzer, A. R., Lynch, S. V., Langelier, C., Christie, J. D., McCauley, K. E., Nelson, M. F., Cheung, C. K., Benowitz, N. L., Cohen, M. J. M., & Calfee, C. S. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0441oc · Cited by 167
Self-citationDonor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation
Agbor-Enoh, S. T., Wang, Y., Tunc, I., Jang, M. K., Davis, A. A., Vlaminck, I. D., Luikart, H. I., Shah, P. D., Timofte, I., Brown, A. W., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.029 · Cited by 155
“We acknowledge that the lack of correlation may be due to the small sample size of our study in relation to prior studies [5].”
ResultSelf-citationMachuca, T., Mercier, O. M., Collaud, S., Tikkanen, J., Krueger, T., Yeung, J. C., Chen, M., Azad, S., Singer, L. G., Yasufuku, K., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13124 · Cited by 152
“While we recognize that this analysis does not account for recipient derived contributions to PGD that clearly exist (38), we also acknowledge that the decision making process during EVLP needs to be made more precise.”
BackgroundOutcomes after transplantation of lungs preserved for more than 12 h: a retrospective study
Yeung, J. C., Krueger, T., Yasufuku, K., de Perrot, M. E., Pierre, A. F., Waddell, T. K., Singer, L. G., Keshavjee, S. H., & Cypel, M. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30323-x · Cited by 151
Bonser, R. S., Taylor, R., Collett, D., Thomas, H., Dark, J. H., & Neuberger, J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60160-3 · Cited by 145
Pulmonary Fibrosis in Sarcoidosis. Clinical Features and Outcomes
Patterson, K. C., & Strek, M. E. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201303-069fr · Cited by 147
Body composition and mortality after adult lung transplantation in the United States
Singer, J. P., Peterson, E. R., Snyder, M. E., Katz, P. P., Golden, J. A., D’Ovidio, F., Bacchetta, M., Sonett, J. R., Kukreja, J., Shah, L., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0973oc · Cited by 133
Self-citationLung size mismatch and primary graft dysfunction after bilateral lung transplantation
Eberlein, M. H., Reed, R. M., Bölükbas, S., Diamond, J. M., Wille, K. M., Orens, J. B., Brower, R. G., & Christie, J. D. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.09.030 · Cited by 131
“Potential confounders were selected into multivariable models based on risk factors previously identified in the literature and plausible association with pTLC-ratio or PGD (2).”
MethodSelf-citationVan Raemdonck, D., Hartwig, M. G., Hertz, M. I., Davis, R. D., Cypel, M., Hayes, D., Ivulich, S., Kukreja, J., Lease, E. D., Loor, G., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.013 · Cited by 128
Self-citationThe Future of Lung Transplantation
Young, K. A., & Dilling, D. F. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.08.1036 · Cited by 139
Morbidity and mortality in sarcoidosis
Gerke, A. K. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000080 · Cited by 126
Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation
Porteous, M. K., Diamond, J. M., & Christie, J. D. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000232 · Cited by 122
Self-citationProtein Expression Profiling Predicts Graft Performance in Clinical Ex Vivo Lung Perfusion
Machuca, T., Cypel, M., Yeung, J. C., Bonato, R., Zamel, R., Chen, M., Azad, S., Hsin, M. K. Y., Saito, T., Guan, Z., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000974 · Cited by 119
Chatterjee, S., Nieman, G. F., Christie, J. D., & Fisher, A. B. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00198.2014 · Cited by 120
Self-citationChristie, J. D., Raemdonck, D. E. V., & Fisher, A. J. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2401039 · Cited by 116
Self-citationMagouliotis, D. E., Tasiopoulou, V. S., Svokos, A. A., Svokos, K. A., & Zacharoulis, D. (2017) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-017-0836-3 · Cited by 101
“The use of CPB support in LuTx has been associated with reperfusion injury and severe PGD [6, 23, 24].”
Gulack, B. C., Hirji, S. A., & Hartwig, M. G. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.06.04 · Cited by 110
Long-term ozone exposure increases the risk of developing the acute respiratory distress syndrome
Ware, L. B., Zhao, Z., Koyama, T., May, A. K., Matthay, M. A., Lurmann, F. W., Balmes, J. R., & Calfee, C. S. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1418oc · Cited by 94
Self-citationBeer, A., Reed, R. M., Bölükbas, S., Budev, M. M., Chaux, G. E., Zamora, M. R., Snell, G. I., Orens, J. B., Klesney‐Tait, J., Schmidt, G. A., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-419oc · Cited by 95
Self-citationEberlein, M. H., Arnaoutakis, G. J., Yarmus, L. B., Feller-Kopman, D. J., Dezube, R., Chahla, M. F., Bölükbas, S., Reed, R. M., Klesney‐Tait, J., Parekh, K. R., et al. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.12.009 · Cited by 102
Self-citationMulligan, M. J., Sánchez, P. G., Evans, C. F., Wang, Y., Kon, Z. N., Rajagopal, K., Iacono, A. T., Gammie, J. S., Griffith, B. P., & Pham, S. M. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.03.096 · Cited by 90
Primary Graft Dysfunction (PGD) Following Lung Transplantation
Shah, R., & Diamond, J. M. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1615797 · Cited by 89
Self-citationWatanabe, T., Cypel, M., & Keshavjee, S. H. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-23 · Cited by 87
“21037/jtd-2021-23 has been shown to affect short- and long-term morbidity and mortality (7-9).”
BackgroundLung donor selection criteria.
Chaney, J., Suzuki, Y., Cantu, E., & van Berkel, V. H. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.03.24 · Cited by 87
“PGD occurs in up to 25% of recipients with associated 30 days Keywords: Lung transplant; donor criteria; review Submitted Feb 04, 2014.”
BackgroundInfluentialSelf-citationLin, F., Jingyuan, X., Liang, F., Huijun, D., Liu, Y., Ren, J., Lin, J., & Linghui, P. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02467-w · Cited by 85
“Introduction Lung ischemia–reperfusion injury (LIRI) is a complex pathophysiological process that occurs as a result of various clinical conditions, such as cardiac arrest, trauma, pulmonary thrombosis, lung transplantation, and cardiopulmonary bypass surgery [1, 2].”
Hartert, M., Şenbaklavacı, Ö., Gohrbandt, B., Fischer, B., Buhl, R., & Vahl, C. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0107 · Cited by 88
Machuca, T., & Cypel, M. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.07.12 · Cited by 84
Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant
Porteous, M. K., Ky, B., Kirkpatrick, J. N., Shinohara, R. T., Diamond, J. M., Shah, R., Lee, J. C., Christie, J. D., & Kawut, S. M. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1522oc · Cited by 84
Self-citationUpala, S., Panichsillapakit, T., Wijarnpreecha, K., Jaruvongvanich, V., & Sanguankeo, A. (2016) · Transplant International · doi:10.1111/tri.12721 · Cited by 81
“Two studies derived from the LTOG database [25,28].”
MethodMiele, C. H., Schwab, K., Saggar, R., Duffy, E., Elashoff, D., Tseng, C.-H., Weigt, S., Charan, D., Abtin, F., Johannes, J., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201512-806oc · Cited by 81
Core Muscle Size Predicts Postoperative Outcome in Lung Transplant Candidates
Weig, T. G., Milger, K., Langhans, B., Janitza, S., Sisic, A., Kenn, K., Irlbeck, T., Pomschar, A., Johnson, T., Irlbeck, M., et al. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.10.041 · Cited by 82
“Obesity is associated with primary graft dysfunction and increased systemic inflammatory response after LT [19, 20].”
Primary Graft Dysfunction After Lung Transplantation
Porteous, M. K., & Lee, J. C. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.07.005 · Cited by 77
Self-citationMarczin, N., de Waal, E. E. C., Hopkins, P. M.-A., Mulligan, M. S., Simon, A. R., Shaw, A., Raemdonck, D. E. V., Neyrinck, A., Gries, C., Algotsson, L., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.012 · Cited by 83
“12 Justification for a paradigm change Such analysis of the state of art highlights the need for anesthesia and intensive care specialties to foster an enhanced role in the entire process of LTx and to take clearer ownership of the total morbidity burden and failure to strive following LTx.”
BackgroundEffect of mode of intraoperative support on primary graft dysfunction after lung transplant
Loor, G., Huddleston, S. J., Hartwig, M. G., Bottiger, B., Daoud, D., Wei, Q., Zhang, Q., Ius, F., Warnecke, G., Villavicencio, M. A., et al. (2022) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.10.076 · Cited by 79
Cognitive Function, Mental Health, and Health-related Quality of Life after Lung Transplantation
Cohen, D. G., Christie, J. D., Anderson, B. J., Diamond, J. M., Judy, R. P., Shah, R., Cantu, E., Bellamy, S. L., Blumenthal, N. P., Demissie, E., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201311-388oc · Cited by 76
Self-citationEarly donor-specific antibodies in lung transplantation: Risk factors and impact on survival
Ius, F., Sommer, W., Tudorache, I., Kühn, C., Avsar, M., Siemeni, T., Salman, J., Hallensleben, M., Kieneke, D., Greer, M., et al. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.015 · Cited by 76
“02 Chronic bacterial colonization 28 (28) 156 (35) 0.”
Salman, J., Ius, F., Sommer, W., Siemeni, T., Kuehn, C., Avsar, M., Boethig, D., Molitoris, U., Bara, C., Gottlieb, J., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx047 · Cited by 76
“Moreover, in this cohort of patients, the development of primary graft dysfunction (PGD) is common complication early postoperatively [6, 7].”
BackgroundContemporary trends in PGD incidence, outcomes, and therapies
Cantu, E., Diamond, J. M., Cevasco, M., Suzuki, Y., Crespo, M. M., Clausen, E. S., Dallara, L., Ramon, C. V., Harmon, M. T., Bermudez, C. A., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.08.013 · Cited by 72
Self-citationİskender, İ., Sakamoto, J., Nakajima, D., Lin, H., Chen, M., Kim, H., Guan, Z., Sorbo, L. D., Hwang, D. M., Waddell, T. K., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.03.006 · Cited by 79
Recent advances in lung transplantation
Meyer, K. C. (2018) · F1000Research · doi:10.12688/f1000research.15393.1 · Cited by 77
Frailty and clinical benefits with lung transplantation
Rozenberg, D., Mathur, S., Wickerson, L. M., Chowdhury, N., & Singer, L. G. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.06.005 · Cited by 72
McGlothlin, D. P., Granton, J. T., Klepetko, W., Beghetti, M., Rosenzweig, E. B., Corris, P. A., Horn, E. M., Kanwar, M. K., McRae, K. M., Román, A., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.06.013 · Cited by 81
“Especially patients with PH are known to develop PGD.231,232 A number of donor, recipient, and procedural characteristics were identified to be associated with the occurrence of PGD in PH patients.233 Most importantly, left ventricular diastolic dysfunction was recently reported to be an independent prognostic risk fa…”
BackgroundShah, R., Diamond, J. M., Cantu, E., Flesch, J. D., Lee, J. C., Lederer, D. J., Lama, V. N., Orens, J. B., Weinacker, A. B., Wilkes, D. S., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13262 · Cited by 74
“67) Low risk 25 6 (2,10) 22 6 (2,13) Low risk þ smoking donor 10 9 (4,15) 5 15 (3,40) High risk 75 16 (13,19) 78 13 (9,17) High risk þ smoking donor 28 26 (21,31) 17 29 (19,42)”
BackgroundSelf-citationMoazed, F., Burnham, E. L., Vandivier, R. W., O’Kane, C. M., Shyamsundar, M., Hamid, U. I., Abbott, J., THICKETT, D. R., Matthay, M. A., McAuley, D. F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207886 · Cited by 66
Geube, M., Perez-Protto, S. E., McGrath, T. L., Yang, D., Sessler, D. I., Budev, M. M., Kurz, A. M., McCurry, K. R., & Duncan, A. E. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001163 · Cited by 69
Porteous, M. K., Lee, J. C., Lederer, D. J., Palmer, S. M., Cantu, E., Shah, R., Bellamy, S. L., Lama, V. N., Bhorade, S. M., Crespo, M. M., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201610-810oc · Cited by 70
Self-citationQuantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant
Cantu, E., Diamond, J. M., Suzuki, Y., Lasky, J., Schaufler, C., Lim, B., Shah, R., Porteous, M. K., Lederer, D. J., Kawut, S. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1140oc · Cited by 65
Self-citationMitochondrial Fission Mediated Cigarette Smoke–induced Pulmonary Endothelial Injury
Wang, Z., White, A., Wang, X., Ko, J., Choudhary, G., Lange, T. S., Rounds, S., & Lü, Q. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0008oc · Cited by 65
Mechanical ventilation for the lung transplant recipient
Barnes, L., Reed, R. M., Parekh, K. R., Bhama, J. K., Pena, T. A., Rajagopal, S., Schmidt, G. A., Klesney‐Tait, J., & Eberlein, M. H. (2015) · Current Pulmonology Reports · doi:10.1007/s13665-015-0114-8 · Cited by 62
Andreasson, A. S. I., Karamanou, D. M., Gillespie, C. S., Özalp, F., Butt, T., Hill, P., Jiwa, K., Walden, H. R., Green, N. J., Borthwick, L. A., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw358 · Cited by 64
Extracorporeal Circulation During Lung Transplantation Procedures: A Meta-Analysis
Hoechter, D. J., Shen, Y. F., Kammerer, T., Guenther, S. P. W., Weig, T. G., Schramm, R., Hagl, C. M., Born, F., Meiser, B., Preißler, G., et al. (2017) · ASAIO Journal · doi:10.1097/mat.0000000000000549 · Cited by 62
Sage, A. T., Richard‐Greenblatt, M., Zhong, K., Bai, X. H., Snow, M. B., Babits, M., Ali, A., Baciu, C., Yeung, J. C., Liu, M., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.03.002 · Cited by 66
Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury
Shaver, C. M., Wickersham, N. E., McNeil, J. B., Nagata, H., Miller, A., Landstreet, S. R., Kuck, J. L., Diamond, J. M., Lederer, D. J., Kawut, S. M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98546 · Cited by 60
“Patients provided informed consent at the time of enrollment into the LTOG study, a multicenter prospective cohort study of patients undergoing lung transplantation designed to evaluate predictors of PGD (5).”
BackgroundMethodSelf-citationPrimary Graft Dysfunction in Lung Transplantation: A Review of Mechanisms and Future Applications
Chacon‐Alberty, L., Fernandez, R., Jindra, P., King, M., Rosas, I. O., Hochman‐Mendez, C., & Loor, G. (2023) · Transplantation · doi:10.1097/tp.0000000000004503 · Cited by 59
Donor Age and Early Graft Failure After Lung Transplantation: A Cohort Study
Baldwin, M. R., Peterson, E. R., Easthausen, I. J., Quintanilla, I., Colago, E., Sonett, J. R., D’Ovidio, F., Costa, J. A., Diamond, J. M., Christie, J. D., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12428 · Cited by 63
“recent study suggests that donor cause of death is not associated with PGD (18).”
BackgroundSelf-citationMachuca, T., Cypel, M., Zhao, Y. D., Grasemann, H., Tavasoli, F., Yeung, J. C., Bonato, R., Chen, M., Zamel, R., Chun, Y.-M., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.01.003 · Cited by 58
Zhao, J., Li, J., Dong, W., Gao, F., Yang, X., Yue, B., Xiong, D., Liu, M., Xu, H., Hu, C., et al. (2023) · Transplantation · doi:10.1097/tp.0000000000004638 · Cited by 57
Prevalence and Impact of Active and Passive Cigarette Smoking in Acute Respiratory Distress Syndrome
Hsieh, S.-J. J., Zhuo, H., Benowitz, N. L., Thompson, B., Liu, K. D., Matthay, M. A., & Calfee, C. S. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000418 · Cited by 58
Delayed chest closure after lung transplantation: Techniques, outcomes, and strategies
Shigemura, N., Orhan, Y., Bhama, J. K., D’Cunha, J., Zaldonis, D. B., Pilewski, J. M., Luketich, J. D., & Bermudez, C. A. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.03.003 · Cited by 56
Martens, A., Boada, M., Vanaudenaerde, B. M., Verleden, S. E., Vos, R., Verleden, G. M., Verbeken, E. K., Raemdonck, D. E. V., Schols, D., Claes, S., et al. (2016) · Transplant International · doi:10.1111/tri.12823 · Cited by 63
“at 72 h after lung transplantation [33].”
BackgroundGlorion, M., Mercier, O. M., Mitilian, D., de Lemos, A., Lamrani, L., Feuillet, S., Pradère, P., Pavec, J. L., Lehouerou, D., Stéphan, F., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy089 · Cited by 57
Hashimoto, K., Höetzenecker, K., Yeung, J. C., Jeagal, L., Donahoe, L. L., Pierre, A. F., de Perrot, M. E., Yasufuku, K., Waddell, T. K., Keshavjee, S. H., et al. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.07.003 · Cited by 56
Postoperative Management of Lung Transplant Recipients in the Intensive Care Unit
Nardo, M. D., Tikkanen, J., Husain, S., Singer, L. G., Cypel, M., Ferguson, N. D., Keshavjee, S. H., & Sorbo, L. D. (2021) · Anesthesiology · doi:10.1097/aln.0000000000004054 · Cited by 66
ICU Care Before and After Lung Transplantation
Fuehner, T., Kuehn, C., Welte, T., & Gottlieb, J. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.02.656 · Cited by 57
Banga, A., Mohanka, M. R., Mullins, J., Bollineni, S., Kaza, V., Ring, S., Bajona, P., Peltz, M., Wait, M. A., & Torres, F. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.07.020 · Cited by 53
Hashimoto, K., Cypel, M., Kim, H. S., Machuca, T., Nakajima, D., Chen, M., Hsin, M. K. Y., Zamel, R., Azad, S., Waddell, T. K., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14160 · Cited by 52
“PGD, with adjustment for known PGD factors (3) as potential con-”
BackgroundMethodProtein biomarkers associated with primary graft dysfunction following lung transplantation
Hamilton, B. C. S., Kukreja, J., Ware, L. B., & Matthay, M. A. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00454.2016 · Cited by 52
Self-citationSmith, P. J., Snyder, L. D., Palmer, S. M., Hoffman, B. M., Stonerock, G. L., Ingle, K., Saulino, C. K., & Blumenthal, J. A. (2017) · Transplant International · doi:10.1111/tri.13094 · Cited by 52
“Additionally, we controlled for PGD in our LOS analyses but, because PGD was the primary determinant of longer LOS and therefore confounded, elected to control for LOS (without PGD) in our survival models, as well as controlling for 6MWD.”
BackgroundSelf-citationWeight loss prior to lung transplantation is associated with improved survival
Chandrashekaran, S., Keller, C. A., Kremers, W. K., Peters, S. G., Hathcock, M. A., & Kennedy, C. C. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.11.018 · Cited by 50
“Longer ischemic and cardiopulmonary bypass times would increase risk of primary graft dysfunction (PGD) and possibly affect mortality.3,5,12,13 Our findings did not support this theory.”
InfluentialSlambrouck, J. V., Raemdonck, D. E. V., Vos, R., Vanluyten, C., Vanstapel, A., Prisciandaro, E., Willems, L., Orlitová, M., Kaes, J., Jin, X., et al. (2022) · Cells · doi:10.3390/cells11040745 · Cited by 56
The endothelium: gatekeeper to lung ischemia-reperfusion injury
Ta, H. Q., Kuppusamy, M., Sonkusare, S. K., Roeser, M. E., & Laubach, V. E. (2024) · Respiratory Research · doi:10.1186/s12931-024-02776-4 · Cited by 50
“29% of transplant patients with IRI will die within 90 days, compared to 5% of recipients without [9].”
BackgroundThe Impact of Anesthetic Management on Perioperative Outcomes in Lung Transplantation
Martin, A. K., Yalamuri, S. M., Wilkey, B., Kolarczyk, L. M., Fritz, A. V., Jayaraman, A. L., & Ramakrishna, H. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.08.037 · Cited by 50
Remote ex vivo lung perfusion at a centralized evaluation facility
Mallea, J. M., Hartwig, M. G., Keller, C. A., Kon, Z. N., Pierson, R. N., Erasmus, D. B., Roberts, M., Patzlaff, N. E., Johnson, D., Sánchez, P. G., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.09.006 · Cited by 51
Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors
Ruttens, D., Martens, A., Ordies, S., Verleden, S. E., Neyrinck, A., Vos, R., Boada, M., Vanaudenaerde, B. M., Verleden, G. M., & Raemdonck, D. E. V. (2017) · Transplantation · doi:10.1097/tp.0000000000001678 · Cited by 48
“And although donor smoking is a known risk factor for PGD development, this was not translated in our results.(12) In conclusion, this correspondence is important because it clearly demonstrates that LTx after DCD donation impacts up to 15% of all our transplant procedures in the time span covered and does result in a…”
BackgroundMiano, T. A., Flesch, J. D., Feng, R., Forker, C. M., Brown, M., Oyster, M. L., Kalman, L., Rushefski, M., Cantu, E., Porteus, M. K., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1629 · Cited by 48
“First, which clinical and pharmacogenetic factors explain early tacrolimus exposure variability? Second, what is the association among early tacrolimus exposure, AKI, and ACR during the immediate postoperative period? To address these questions, we conducted a retrospective analysis of patients from one center of the…”
MethodSelf-citationHeart–lung vs. double‐lung transplantation for idiopathic pulmonary arterial hypertension
Hill, C. C., Maxwell, B. G., Boulate, D., Haddad, F., Ha, R. V., Afshar, K., Weill, D., & Dhillon, G. S. (2015) · Clinical Transplantation · doi:10.1111/ctr.12628 · Cited by 48
“Previous studies have demonstrated that transplant recipients with IPAH are at higher risk of post-transplant graft dysfunction (11, 13, 14), and PGD is a leading cause of early mortality in these patients (6, 14).”
BackgroundTransplantation, bridging, and support technologies in pulmonary hypertension
Savale, L., Benazzo, A., Corris, P. A., Keshavjee, S. H., Levine, D. J., Mercier, O. M., Davis, R. D., & Granton, J. T. (2024) · European Respiratory Journal · doi:10.1183/13993003.01193-2024 · Cited by 53
“A number of donor, recipient and procedural characteristics were identified to be associated with the occurrence of PGD [108].”
Niethamer, T. K., Planer, J. D., Morley, M. P., Babu, A., Zhao, G., Basil, M. C., Cantu, E., Frank, D. B., Diamond, J. M., Nottingham, A. N., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2024.12.002 · Cited by 52
Self-citationC1-Esterase-Inhibitor for Primary Graft Dysfunction in Lung Transplantation
Sommer, W., Tudorache, I., Kühn, C., Avsar, M., Salman, J., Ius, F., Gras, C., Weber, P., Welte, T., Gottlieb, J., et al. (2014) · Transplantation · doi:10.1097/tp.0000000000000034 · Cited by 47
Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions
Siddiqui, F. M., & Diamond, J. M. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000452 · Cited by 47
Self-citationSmith, P. J., Blumenthal, J. A., Hoffman, B. M., Rivelli, S. K., Palmer, S. M., Davis, R. D., & Mathew, J. P. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201507-454oc · Cited by 46
“Grading of primary graft dysfunction was determined by International Society of Heart and Lung Transplantation guidelines(12) using the ratio of partial oxygen pressure to fraction of inspired oxygen (P/F ratio) assessed at 72 hours after transplant.(13, 14) Because Page 5 of 27 ANNALSATS Articles in Press.”
MethodSelf-citationMartin, A. K., Mercier, O. M., Fritz, A. V., Gelzinis, T. A., Höetzenecker, K., Lindstedt, S., Marczin, N., Wilkey, B., Schecter, M. G., Lyster, H. S., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.08.027 · Cited by 58
Self-citationExtracorporeal Life Support in Lung Transplantation
Abrams, D. C., Brodie, D., & Arcasoy, S. M. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.07.006 · Cited by 47
Self-citation
Metadata
- Authors
- Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., Lederer, D. J., Cantu, E., Kohl, B. A., Lama, V. N., Bhorade, S. M., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, A. S., Weinacker, A., Arcasoy, S., Shah, P. D., Wilkes, D. S., Ware, L. B., Palmer, S. M., & Christie, J. D.
- Affiliations
- University of Pennsylvania (US)
- Columbia University (US)
- University of Michigan (US)
- University of Chicago (US)
- University of Pittsburgh (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Stanford University (US)
- Indiana University Indianapolis (US)
- Vanderbilt University (US)
- Duke University (US)
- Corresponding author
- Diamond, Joshua M.
- ORCID
- Diamond, Joshua M.
- Kawut, Steven M.
- Shah, Rupal J.
- Localio, A. Russell
- Bellamy, Scarlett L.
- Lederer, David J.
- Cantu, Edward
- Kohl, Benjamin A.
- Lama, Vibha N.
- Bhorade, Sangeeta M.
- Crespo, Maria
- Wille, Keith
- Shah, Ashish S.
- Weinacker, Ann
- Arcasoy, Selim
- Shah, Pali D.
- Wilkes, David S.
- Ware, Lorraine B.
- Palmer, Scott M.
- Christie, Jason D.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 187
- Issue
- 5
- Pages
- 527-534
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC3733407
- OpenAlex
- W2073264366
- Cited by
- 687
- References
- 34
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 73 · 2023: 65 · 2022: 54 · 2021: 58 · 2020: 46 · 2019: 44 · 2018: 48 · 2017: 53 · 2016: 46 · 2015: 42 · 2014: 45 · 2013: 15
- FWCI
- 48.59
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL096845, K24HL103836, R01HL114626, R01HL081619, R01HL087115, K23HL116656, K24HL115354)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- primary graft dysfunction, lung transplantation, risk factors, fraction of inspired oxygen, single lung transplantation, cardiopulmonary bypass, obesity, sarcoidosis, pulmonary arterial hypertension, mean pulmonary artery pressure, donor-recipient mismatch, donor sex, donor body mass index
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Multivariate Analysis, Logistic Models, Lung Transplantation, Primary Graft Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.